Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational studyResearch in context

• Main Authors: Mangaiarkarasi S. Asokan (Author), Roshni Florina Joan (Author), Sudhir Babji (Author), Girish Dayma (Author), Prajitha Nadukkandy (Author), Vinutha Subrahmanyam (Author), Archana Pandey (Author), Girish Malagi (Author), Pooja Arya (Author), Vibhuti Mahajan (Author), Jayateerth Bhavikatti (Author), Ketakee Pawar (Author), Aishwarya Thorat (Author), Priyanki Shah (Author), Ramakrishna B. Goud (Author), Bishnudeo Roy (Author), Shon Rajukutty (Author), Sushil Immanuel (Author), Dhiraj Agarwal (Author), Sankhanil Saha (Author), Akshatha Shivaraj (Author), Patricia Panikulam (Author), Rajeshwari Shome (Author), Shah- (Author), Anusmrithi U. Sharma (Author), Ajinkya Naik (Author), Shruti Talashi (Author), Madhuri Belekar (Author), Ritu Yadav (Author), Poornima Khude (Author), Mamatha V (Author), Sudarshan Shivalingaiah (Author), Urmila Deshmukh (Author), Chinmayee Bhise (Author), Manjiri Joshi (Author), Leeberk Raja Inbaraj (Author), Sindhulina Chandrasingh (Author), Aurnab Ghose (Author), Colin Jamora (Author), Anandi S. Karumbati (Author), Varadharajan Sundaramurthy (Author), Avita Johnson (Author), Naveen Ramesh (Author), Nirutha Chetan (Author), Chaitra Parthiban (Author), Asma Ahmed (Author), Srabanti Rakshit (Author), Vasista Adiga (Author), George D'souza (Author), Vinay Rale (Author), Carolin Elizabeth George (Author), Jacob John (Author), Anand Kawade (Author), Akanksha Chaturvedi (Author), Anu Raghunathan (Author), Mary Dias (Author), Anand Bhosale (Author), Padinjat Raghu (Author), L.S. Shashidhara (Author), Annapurna Vyakarnam (Author), Vineeta Bal (Author), Gagandeep Kang (Author), Satyajit Mayor (Author)
• Format: Book
• Published: Elsevier, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: There are limited global data on head-to-head comparisons of vaccine platforms assessing both humoral and cellular immune responses, stratified by pre-vaccination serostatus. The COVID-19 vaccination drive for the Indian population in the age group 18-45 years began in April 202...